FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Expanded Use of Prograf Relied on RWE

FDA approves a new use for Astellas Pharmas Prograf (tacrolimus), based on real-world, for use in combination with other immunosuppressant drugs to pr...

Human Drugs

Shift to Include Pregnant Women in Trials: FDA

FDA pushes for a major paradigm shift to move the clinical development community from systemic exclusion to the inclusion of pregnant and breastfeedin...

Medical Devices

Aortic Aneurysm Device is Breakthrough

FDA grants Endologix a breakthrough device designation for its ChEVAS (Chimney EndoVascular Aneurysm Sealing) System, an endovascular abdominal aortic...

Human Drugs

Ardelyx Tenapanor NDA Hits FDA Snag

Ardelyx says FDA found deficiencies in the NDA review for tenapanor that preclude discussion of labeling and post-marketing requirements/commitments a...

Medical Devices

Nevro OKd for Treating Diabetic Neuropathy

FDA approves a Nevro Corp. PMA for its Senza System for treating chronic pain associated with painful diabetic neuropathy.

Federal Register

Latest Federal Register Notices

FDA Review posts the Federal Regiter notices for the week ending 7/16/2021.

Biologics

Pfizer Covid Vaccine BLA Decision Due 1/2022

FDA grants Pfizer/BioNTech a priority review (user fee action due 1/2022) for a BLA for their mRNA vaccine to prevent Covid-19 in individuals 16 years...

Medical Devices

KorvaLabs Covid Test EUA Revoked

KorvaLabs requests that its emergency use authorization for the Curative SARS-Cov-2 (Covid-19) test be revoked because it is now using different EUA-a...

Medical Devices

Dexcom 510(k) on 3rd Party Programming Interface

FDA clears a Dexcom 510(k) for its Dexcom Partner Web application programming interface to enable invited third-party developers to integrate real-tim...

Human Drugs

Kadmon Pharmas Rezurock Approved by FDA

FDA approves a Kadmon Pharmaceuticals NDA for Rezurock (belumosudil), a kinase inhibitor for treating certain adult and pediatric patients 12 years an...